How DeLorean AI Is Transforming Kidney Disease Detection With Predictive Tech
Severence MacLaughlin, Founder & CEO of DeLorean AIDeLorean AIChronic kidney disease (CKD) has long been a silent killer and the...
Year: 2025
Screening and diagnosis of metabolic dysfunction-associated steatotic liver disease in children within public healthcare
Patients and study designThe study was conducted at the Tampere Center for Child, Adolescent, and Maternal Health Research, Tampere University,...
Liver cancer patient finds hope in histotripsy treatment amid rare diagnosis
GRAND RAPIDS, Mich. — One year ago, University of Michigan Health-West launched a cancer treatment option called histotripsy. It uses...
Addressing global variation and systemic inequities in access to liver transplantation
The global burden of liver disease continues to increase and now accounts for one in every twenty five deaths worldwide1....
AI-Driven Alerts Could Reduce Kidney Complications Following Cardiac
A groundbreaking collaboration between Rice University and Baylor College of Medicine (BCM) is set to radically transform the way acute...
Fresenius Medical Care Presents 31-Day AI Model at ASN 2025
Fresenius Medical Care researchers will present multiple abstracts that demonstrate proven, real-world benefits of hemodiafiltration (HDF), with one accepted as...
